Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 521 - Heterocyclic compounds containing unspecified hetero rings
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
11/2002
11/07/2002WO2002087571A1 Aromatase inhibitors as novel veterinary drugs
11/07/2002US20020165275 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/07/2002US20020165259 Such as ethyl-3-((E)-2-acetamido-thiazol-5-yl)-acrylate for treatment of cancer, proliferative diseases, inflammation, and arthritis
11/07/2002US20020165253 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors
11/07/2002US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002CA2445568A1 Triazole-derived kinase inhibitors and uses thereof
11/06/2002EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002EP0871619B1 Phenyl thiazole derivatives with anti herpes virus properties
11/06/2002CN1378534A Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of coagulation cascade
11/06/2002CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002CN1378450A Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
11/05/2002US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002US6476054 Cyclic amine modulators of chemokine receptor activity
11/05/2002US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
10/2002
10/31/2002WO2002085907A1 Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists
10/31/2002WO2002085866A1 Novel compounds
10/31/2002WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002WO2002085850A1 Cyclic amidine derivative
10/31/2002WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002US20020161022 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/31/2002US20020161019 For treatment of depression, anxiety, feeding disorders, headache, drug addiction, inflammatory disorders
10/31/2002US20020161008 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression
10/31/2002US20020161000 Treating diseases resulting from tissue breakdown such as heart disease, multiple sclerosis, osteo- and rheumatoid arthritis, atherosclerosis, and osteoporosis
10/31/2002CA2444381A1 Novel compounds
10/31/2002CA2443556A1 Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists
10/30/2002EP1252146A1 Amide compounds for inhibiting protein kinases
10/30/2002CN1377345A Herbicidally active pyridine sulfonyl urea derivatives
10/30/2002CN1377344A Inhibitor of cysteinyl aspartic acid proteinase
10/30/2002CN1093536C 5-lipoxygenase inhibitor
10/29/2002US6472387 Methods of using compounds as neuro-protective agents
10/24/2002WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002US20020156292 Anticancer agents
10/24/2002CA2444264A1 Prodrugs via acylation with cinnamate
10/23/2002EP1250326A2 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation
10/23/2002EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002EP1073642B1 The use of dihydropyrimidines as medicaments, and novel substances for the treatment of hepatitis b
10/23/2002EP0888361B1 Disubstituted methylidene hydrazinophenyl sulphonyl ureas, process for their production and their use as herbicides and plant growth regulators
10/23/2002EP0783499B1 Benzofuran derivatives as tachykinin antagonists
10/23/2002EP0767170B1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
10/23/2002CN1376153A Amide compounds
10/23/2002CN1376149A 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
10/23/2002CN1376148A Rate-controlled particles
10/22/2002US6469021 Non-peptide antagonists of GLP-1 receptor and methods of use
10/17/2002WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002WO2002081433A1 Sulphones which modulate the action of gamma secretase
10/17/2002WO2002066468A3 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
10/17/2002WO2002062301A3 Method and composition for rejuvinating cells, tissues, organs, hair and nails
10/17/2002WO2002044156A3 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
10/17/2002US20020151715 Imidazole derivatives
10/17/2002US20020151535 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent
10/17/2002US20020148052 Such as 4-amino-2-(2-dimethylamino-ethyl)-phenol; useful in place of p-aminophenol
10/16/2002EP1249233A1 Npyy5 antagonists
10/16/2002EP1248783A1 Arylsulfonic acid salts of pyrimidine-based antiviral agents
10/16/2002EP0869938B1 Novel vinyl sulfide compounds and a process for their preparation
10/16/2002CN1374955A Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
10/16/2002CN1092645C Prevention/remedies for complication of diabetes
10/15/2002US6465650 Intermediate steps in preparing peptide nucleic acids
10/15/2002US6465472 Substituted quinazolines and analogs and use thereof
10/15/2002US6465459 Inhibit the enzyme, factor xa
10/15/2002US6464731 Cationic monobenzene nitrophenylenediamines, their use in dyeing keratinous fibers, dyeing compositions comprising them and dyeing processes
10/15/2002CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/10/2002WO2002079192A1 Novel tyrosine kinase inhibitors
10/10/2002WO2002079152A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002WO2002079144A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002US20020144359 Derivatives of 2-aminophenol; providing good oxidative coloration of hair and for providing acceptable light fastness, selectivity, fastness to shampooing
10/10/2002US20020144357 Benzene-1,4-diamine compounds having a weaker sensitization potential than p-phenylenediamine
10/10/2002DE10115994A1 (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel (P-amino-hydroxyphenyl) acrylamide derivatives and compositions containing these compounds colorant
10/10/2002CA2443304A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002CA2442428A1 Novel tyrosine kinase inhibitors
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
10/09/2002CN1373757A Heterocyclically substd, benzoylguanidine, method for production thereof, use thereof as medicament or means of diagnosis and medicaments contg. same
10/09/2002CN1092193C Prolylendopeptidase inhibitors
10/08/2002USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
10/08/2002US6461389 Hair dye
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002US20020143176 For therapy of diseases associdated with Factor VIIa and or inosine monophosphate dehydrogenase (IMPDH)
10/03/2002US20020143023 Dihydropyrimidine compounds and compositions containing the same
10/03/2002US20020143011 Tri-substituted phenyl derivatives and processes for their preparation
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/02/2002EP1244658A2 Azolyl-alkyl azole derivatives, a method for their production and their use as pesticides
10/02/2002EP1244641A1 Thiazolyl amide derivatives
10/02/2002EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
10/02/2002EP0877730B1 Aryl acrylics for use as fungicide
10/02/2002EP0839035B1 Antifungal agent, compound therefor, process for producing the same
10/02/2002CN1372557A Neurotrophin production/secretion promoting agent
10/02/2002CN1091596C Anti fungal agent, compound therefor, process for producing the same
10/01/2002US6458959 Anti-herpesvirus compounds and methods for identifying, making and using same
10/01/2002US6458953 Valency platform molecules comprising carbamate linkages
10/01/2002US6458806 Aryl alkenamides derivatives as MCP-1 antagonists
10/01/2002US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf).
09/2002
09/26/2002WO2002074768A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
09/26/2002WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002WO2002074753A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 163